Page last updated: 2024-09-02

liquiritigenin and Diabetic Glomerulosclerosis

liquiritigenin has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, H; Shi, J; Zhu, X	1

Other Studies

1 other study(ies) available for liquiritigenin and Diabetic Glomerulosclerosis

Article	Year
Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cytoprotection; Diabetic Nephropathies; Dose-Response Relationship, Drug; Extracellular Matrix; Flavanones; Glomerulonephritis; Glucose; Inflammasomes; Inflammation Mediators; Mesangial Cells; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Signal Transduction	2018

Article

Year

Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cytoprotection; Diabetic Nephropathies; Dose-Response Relationship, Drug; Extracellular Matrix; Flavanones; Glomerulonephritis; Glucose; Inflammasomes; Inflammation Mediators; Mesangial Cells; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Signal Transduction

2018